335 related articles for article (PubMed ID: 19605908)
21. Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers.
Fujimoto J; Toyoki H; Sato E; Sakaguchi H; Jahan I; Alam SM; Tamaya T
J Biomed Sci; 2006 Nov; 13(6):825-32. PubMed ID: 17013750
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 expression in animal cancers.
Doré M
Vet Pathol; 2011 Jan; 48(1):254-65. PubMed ID: 20876365
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
[TBL] [Abstract][Full Text] [Related]
24. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
[TBL] [Abstract][Full Text] [Related]
25. Tryptase-positive mast cells correlate with angiogenesis in canine mammary carcinoma.
Im KS; Kim JH; Yhee JY; Yu CH; Kim NH; Nho WG; Sur JH
J Comp Pathol; 2011; 144(2-3):157-63. PubMed ID: 20934709
[TBL] [Abstract][Full Text] [Related]
26. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
27. Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours.
Knottenbelt C; Mellor D; Nixon C; Thompson H; Argyle DJ
J Small Anim Pract; 2006 Apr; 47(4):196-200. PubMed ID: 16573762
[TBL] [Abstract][Full Text] [Related]
28. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
29. Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression.
Wendum D; Boëlle PY; Rigau V; Sebbagh N; Olschwang S; Mourra N; Parc R; Trugnan G; Masliah J; Fléjou JF
Virchows Arch; 2003 Feb; 442(2):111-7. PubMed ID: 12596060
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
31. COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy.
Belshaw Z; Constantio-Casas F; Brearley MJ; Dunning MD; Holmes MA; Dobson JM
Vet Comp Oncol; 2011 Jun; 9(2):141-8. PubMed ID: 21569199
[TBL] [Abstract][Full Text] [Related]
32. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
33. Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer.
Fujimoto J; Toyoki H; Sakaguchi H; Jahan I; Alam SM; Tamaya T
Oncol Rep; 2006 Jan; 15(1):21-5. PubMed ID: 16328030
[TBL] [Abstract][Full Text] [Related]
34. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
35. Expression of cyclooxygenase-2 in canine nasal carcinomas.
Impellizeri JA; Esplin DG
Vet J; 2008 Jun; 176(3):408-10. PubMed ID: 17517527
[TBL] [Abstract][Full Text] [Related]
36. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.
Carvalho MI; Pires I; Prada J; Raposo TP; Gregório H; Lobo L; Queiroga FL
Vet Comp Oncol; 2017 Jun; 15(2):619-631. PubMed ID: 26792550
[TBL] [Abstract][Full Text] [Related]
37. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
Rodo A; Malicka E
Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
[TBL] [Abstract][Full Text] [Related]
39. EGFR and microvessel density in canine malignant mammary tumours.
Carvalho MI; Guimarães MJ; Pires I; Prada J; Silva-Carvalho R; Lopes C; Queiroga FL
Res Vet Sci; 2013 Dec; 95(3):1094-9. PubMed ID: 24091029
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]